Enhanced detection of reversible myocardial hypoperfusion by technetium 99m-tetrofosmin imaging and first-pass radionuclide angiography after nitroglycerin administration

Journal of Nuclear Cardiology

Volumn 5, Issue 5, 1998, Pages 469-476

  Peix, Amalia ^a   López, Adlin ^a   Ponce, Felizardo ^a   Morales, Jorge ^a   De La Vega, Adolfo Rodríguez ^a   Chesa, Catalina Sin ^a   Maltas, Ana Ma ^a   García Barreto, David ^a  

^a Cuban Institute of Cardiology   (Cuba)

Author keywords

First pass radionuclide angiography; Myocardial scintigraphy; Nitroglycerin; Tetrofosmin

Indexed keywords

GLYCERYL TRINITRATE; TETROFOSMIN TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REVASCULARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REST; SCINTIANGIOGRAPHY; SUBLINGUAL DRUG ADMINISTRATION;

EID: 0031729966     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(98)90177-5     Document Type: Article

References (38)

1. Kelley JD, Forster AM, Higley B, et al. Technetium-99m-tetrofosmin: a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993;34:222-7.
2. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2 bis (bis (2-ethoxyethyl) phosphino) ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
3. Heo J, Cave V, Wasserleben V, Iskandrian AS. Planar and tomographic imaging with technetium 99m-labeled tetrofosmin. Correlation with thallium-201 and coronary angiography. J Nucl Cardiol 1994;1:317-24.
4. Tamaki N, Takahashi N, Kawamoto M, et al. Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
5. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994;35:587-93.
6. 99mTc-tetrofosmin imaging? A quantitative study using serial planar imaging. Circulation 1992;86:1-46.
7. Abrams J. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B-42B.
8. He ZX, Verani MS, Liu XJ. Nitrate-augmented myocardial imaging for assessment of myocardial viability. J Nucl Cardiol 1995;2:352-7.
9. He ZX, Darcourt J, Guigner A, et al. Nitrates improve detection of ischemic but viable myocardium by thallium-201 rejection SPECT. J Nucl Med 1993;34:1472-7.
10. Galli M, Marcassa C, Imparato A, Campini R, Orrego PS, Giannuzi P. Effects of nitroglycerin by technetium-99m-sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843-8.
11. Maurea S, Cuocolo A, Soficelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
12. Bisi G, Sciagra R, Santoro GM, Rossi V, Fazzini PF. Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recovery. J Nucl Med 1995;36:1994-2000.
13. Bedman DS, Eat H, Van Train K, et al. Myocardial perfusion imaging with technetium-99m-sestamibi: comparative analysis of available imaging protocols. J Nucl Med 1994;35:681-8.
14. Berman DS, Germano G, Kiat H, Friedman J. Simultaneous perfusion/function imaging. J Nucl Cardiol 1995;2:271-3.
15. Villanueva-Meyer J, Mena I, Narahara KA. Simultaneous assessment of left ventricular wall motion and myocardial perfusion with technetium-99m-methoxy-isobutyl-isonitrile at stress and rest in patients with angina: comparison with thallium-201 SPECT. J Nucl Med 1990;31:457-63.
16. Port S. Recent advances in first-pass radionuclide angiography. Cardiology Clin 1994;12:359-72.
17. Friedman J, Berman DS, Kiat H, et al. Rest and treadmill exercise first-pass radionuclide ventriculography: validation of left ventricular ejection fraction measurements. J Nucl Cardiol 1994;1:382-8.
18. Siegel S. Diseño experimental no paramétrico. La Habana: Instituto Cubano del Libra; 1972. p. 86-91.
19. Brown BG, Bolson EL, Petersen RB, Pierre CD, Dodge HT. The mechanism of nitroglycerin action: stenosis vasodilation as a major component of the drug response. Circulation 1981;64:1089-97.
20. Brown BG. Response of normal and diseased epicardial coronary arteries to vasoactive drugs: quantitative arteriographic studies. Am J Cardiol 1985;56:23E-29E.
21. Cohen MV, Sonnenblick EH, Kirk ES. Comparative effects of nitroglycerin and isosorbide dinitrate on coronary collateral vessels and ischemic myocardium in dogs. Am J Cardiol 1976;37:244-9.
22. Aoki M, Sakai K, Koyanagi S, Takeshita A, Nakamura M. Effect of nitroglycerin on coronary collateral function during exercise evaluated by quantitative analysis of thallium-201 SPECT. Am Heart J 1991;121:1361-5.
23. Burak Z, Akin H, Buket S, et al. Comparison of Tc-99m-tetrofosmin and thallium-201 reinjection in diagnosis of viable myocardium (Abstract). Eur J Nucl Med 1996;23:1160.
24. 201T1 for myocardial viability determination (Abstract). Eur J Nucl Med 1996;23:1160.
25. Sinusas AJ, Shi Q, Saltzberg MT, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71.
26. Maublant JC, Gachon P, Moins N. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med 1988;29:48-54.
27. Sinusas AJ, Trautman KA, Bergin JD, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990;82:1424-37.
28. 201T1 to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990;81:289-96.
29. Mehry H, Latour JG, Arsenault A, Rousseau G. Effect of coronary reperfusion on technetium-99m methoxyisobutylisonitrile uptake by viable and necrotic myocardium in the dog. Eur J Nucl Med 1992;19:503-10.
30. 99mTc-sestamibi defect size. Circulation 1993;88:2224-34.
31. Derebek E, Kozan O, Durak H, et al. Tc-99m-tetrofosmin perfusion imaging under the effect of sublingual nitrate in the detection of viable myocardium (Abstract). Eur J Nucl Med 1996;23:1163.
32. Flotats A, Carrio I, Estorch M, Bema LI, Catafau AM, Ballester M. Nitrate administration to enhance detection of myocardial viability by Tc-99m-tetrofosmin SPECT (Abstract). Eur J Nucl Med 1996;23:1042.
33. Cuocolo A, Nappi A, Nicolai E, et al. Tc-99m-tetrofosmin uptake after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic activity by F-18 FDG PET imaging (Abstract). Eur J Nucl Med 1996;23:1152.
34. Gropler R, Bergmann S. Myocardial viability: what is the definition? J Nucl Med 1991;32:10-2.
35. Abrams J. Hemodynamic effects of nitroglycerin and long nitrates. Am Heart J 1985;110:216-24.
36. Fujita M, Yamanishi K, Hirai T, et al. Significance of collateral circulation in reversible left ventricular asynergy by nitroglycerin in patients with relatively recent myocardial infarction. Am Heart J 1990;120:521-8.
37. Helfant RH, Pine R, Meister SG, Feldman MS, Trout RG, Banka VS. Nitroglycerin to unmask reversible asynergy. Correlation with post coronary bypass ventriculography. Circulation 1974;50:108-13.
38. Chesebro JH, Ritman EL, Frye RL, et al. Regional myocardial wall thickening response to nitroglycerin. A predictor of myocardial response to aortocoronary bypass surgery. Circulation 1978;57:952-7.